3rd mRNA Process Development & Manufacturing Summit Europe

The 3rd mRNA Process Development & Manufacturing Summit Europe is scheduled for May 6–8, 2025, in Berlin, Germany. This premier industry-focused forum is dedicated to optimizing process development for mRNA therapeutics and vaccines. The event will address end-to-end process optimization, regulatory compliance to streamline approvals, and advancements in scalable and cost-efficient manufacturing solutions, supporting drug developers in delivering safer and more effective mRNA drugs to patients faster. Notable speakers include Covadonga Paneda, Chief Operating Officer at Altamira Therapeutics; Markus Bergmann, Global Program Head Personalized Cancer Vaccines at CureVac SE; and Sukrut Somani, Director of Chemistry Manufacturing & Controls at BioNTech. Their presentations will provide valuable insights into the latest advancements in mRNA process development and manufacturing. The summit also offers opportunities for networking with key industry players, making it a must-attend event for professionals looking to enhance their mRNA development and manufacturing strategies.